Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,376–7,400 of 7,816 matching trials · page 296 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
Effects of Music Therapy on Huntington's Disease NCT00178360 Music Therapy Runs in: United States · 1 site	PHASE1 other	COMPLETED	11	University of Rochester OTHER	2011-08-22
Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients NCT00281749 TELEPHONE CALL Runs in: United States · 2 sites	PHASE1 other	COMPLETED	—	Maimonides Medical Center OTHER	2011-08-18
BRAF V600E Mutations In Papillary Thyroid Carcinoma NCT01417442 BRAF V600E POSITIVITY Runs in: Turkey (Türkiye) · 1 site	EARLY_PHASE1 other	UNKNOWN	150	Bezmialem Vakif University OTHER	2011-08-16
Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease NCT01125631 PF-04360365 8.5 mg/kg; Placebo Runs in: Japan · 4 sites	PHASE1 other	COMPLETED	8	Pfizer INDUSTRY	2011-08-12
Pain in Patients With Dementia and Behavioural Disturbances NCT01021696 Paracetamol; Morphine; Buprenorphine plaster; Pregabalin Runs in: Norway · 18 sites	PHASE2\|PHASE3 other	COMPLETED	352	University of Bergen OTHER	2011-08-10
Rosiglitazone Effects on Cognition for Adults in Later Life NCT00242593 Rosiglitazone Runs in: United States · 3 sites	PHASE2 other	UNKNOWN	120	University of Washington OTHER	2011-08-05
Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized NCT01403519 Runs in: Israel · 1 site	NA other	UNKNOWN	70	Rambam Health Care Campus OTHER	2011-07-27
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) NCT00622713 Rivastigmine transdermal patch Runs in: France · 1 site	PHASE4 symptomatic-cholinergic	COMPLETED	228	Novartis INDUSTRY	2011-07-26
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558 NCT01217021 [18F] MNI-558 Runs in: United States · 1 site	EARLY_PHASE1 other	COMPLETED	10	Institute for Neurodegenerative Disorders OTHER	2011-07-25
Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease NCT01120002 Tamibarotene; Placebo Runs in: Japan · 1 site	PHASE2 other	UNKNOWN	50	Osaka City University OTHER	2011-07-22
Change in Executive Function and IADL Using a Virtual Supermarket Environment Among People With MCI NCT01103453 Virtual Action Planning Supermarket (VAP-S) Software Runs in: Israel · 1 site	PHASE1 other	UNKNOWN	10	Carmel Medical Center OTHER	2011-07-21
Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease NCT01189084 Observational Runs in: Taiwan · 2 sites	NA other	COMPLETED	14	United Biomedical INDUSTRY	2011-07-13
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease NCT01195389 Resonator Runs in: United States · 1 site	NA other	UNKNOWN	30	pico-tesla Magnetic Therapies, LLC INDUSTRY	2011-07-08
Preventing Aggression In Veterans With Dementia (PAVED) - Telephone Sub-Study With Rural Veterans NCT01385007 Preventing Aggression in Veterans with Dementia (PAVeD)	NA other	UNKNOWN	40	Michael E. DeBakey VA Medical Center OTHER_GOV	2011-06-29
Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation NCT01378026	NA other	UNKNOWN	120	China Medical University Hospital OTHER	2011-06-22
Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study NCT00216593 galantamine hydrobromide	PHASE3 symptomatic-cholinergic	COMPLETED	415	Janssen Pharmaceutica N.V., Belgium INDUSTRY	2011-06-21
ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children NCT01374737 Dexmedetomidine Runs in: South Korea · 1 site	PHASE4 other	UNKNOWN	25	Seoul National University Hospital OTHER	2011-06-16
An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia NCT01245530 Aricept; INM-176 Runs in: South Korea · 1 site	PHASE3 other	COMPLETED	280	Whanin Pharmaceutical Company INDUSTRY	2011-06-13
A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia NCT00035191 galantamine	PHASE3 symptomatic-cholinergic	COMPLETED	254	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08
A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease NCT00035204 galantamine	PHASE4 symptomatic-cholinergic	COMPLETED	63	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia NCT00210548 paliperidone palmitate	PHASE3 other	COMPLETED	366	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia NCT00210717 paliperidone palmitate	PHASE3 other	COMPLETED	748	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment NCT00236431 Galantamine hydrobromide	PHASE3 symptomatic-cholinergic	COMPLETED	1,063	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment NCT00236574 Galantamine hydrobromide	PHASE3 symptomatic-cholinergic	COMPLETED	974	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08
A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia NCT00416169 galantamine hydrobromide	PHASE2 symptomatic-cholinergic	COMPLETED	41	Johnson & Johnson Pharmaceutical Research & Development, L.L.C. INDUSTRY	2011-06-08

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →